Your browser doesn't support javascript.
loading
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis.
Parry, Helen; Bruton, Rachel; Tut, Gokhan; Ali, Myah; Stephens, Christine; Greenwood, David; Faustini, Sian; Hughes, Sam; Huissoon, Aarnoud; Meade, Rory; Brown, Kevin; Amirthalingam, Gayatri; Otter, Ashley; Hallis, Bassam; Richter, Alex; Zuo, Jianmin; Moss, Paul.
Afiliación
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Ali M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Greenwood D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Faustini S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Hughes S; Department of Immunology, Birmingham Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
  • Huissoon A; Department of Immunology, Birmingham Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
  • Meade R; Harborne Medical Practice, Harborne, Birmingham, UK.
  • Brown K; National Infection Service, Public Health England, Colindale, London, UK.
  • Amirthalingam G; National Infection Service, Public Health England, Colindale, London, UK.
  • Otter A; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
  • Richter A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Lancet Healthy Longev ; 2(9): e554-e560, 2021 09.
Article en En | MEDLINE | ID: mdl-34401865
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Aged80 / Humans Idioma: En Revista: Lancet Healthy Longev Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Aged80 / Humans Idioma: En Revista: Lancet Healthy Longev Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido